AMY BEARD: Open Payments
NPI 1598425670 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,914 in 83 payments from 13 companies in 2025. Trend: 2023 $2,130 · 2024 $1,134 · 2025 $1,914
Food & beverage: $1,914
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $718 |
| Ardelyx, Inc. | 13 | $269 |
| Phathom Pharmaceuticals, Inc. | 11 | $195 |
| Janssen Biotech, Inc. | 8 | $167 |
| Gilead Sciences, Inc. | 1 | $135 |
| Lilly USA, LLC | 1 | $101 |
| Intercept Pharmaceuticals, Inc. | 1 | $100 |
| Madrigal Pharmaceuticals | 3 | $82 |
| GENZYME CORPORATION | 3 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
Products named: RINVOQ, IBSRELA, VOQUEZNA, SKYRIZI, TREMFYA, Livdelzi, MAVYRET, LINZESS.
Industry payments across FL — which companies pay providers there.
